Activity of the Extracts and Neolignans from Piper regnellii against Methicillin-Resistant Staphylococcus aureus (MRSA)

被引:17
作者
Basilio Marcal, Flaviano Joao [2 ]
Garcia Cortez, Diogenes Aparicio [3 ]
Ueda-Nakamura, Tania [1 ]
Nakamura, Celso Vataru [1 ]
Dias Filho, Benedito Prado [1 ]
机构
[1] Univ Estadual Maringa, Dept Ciencias Basicas Saude, BR-87020900 Maringa, Parana, Brazil
[2] Univ Estadual Maringa, Programa Posgrad Ciencias Farmaceut, BR-87020900 Maringa, Parana, Brazil
[3] Univ Estadual Maringa, Dept Farm & Farmacol, BR-87020900 Maringa, Parana, Brazil
关键词
Piper regnellii; Staphylococcus aureus; neolignans; MRSA; antibacterial activity; VANCOMYCIN;
D O I
10.3390/molecules15042060
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Piper regnellii (Miq.) C. DC. var. pallescens (C. DC.) Yunck (Piperaceae) is a medicinal plant traditionally used in Brazil to treat infectious diseases. The extracts obtained of the leaves from P. regnellii were investigated for their antibacterial activities against methicillin-resistant Staphylococcus aureus (MRSA). The ethyl acetate extract presented a good activity against MRSA, with minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of 16 mu g/mL. Based on this finding, the ethyl acetate extract was fractionated by silica gel column chromatography into nine fractions. The hexane fraction was active against MRSA (MIC at 4 mu g/mL). Further column chromatography separation of the hexane fraction afforded the pure compound eupomatenoid-5. The structure of the compound was established by spectral data (H-1 and C-13 NMR HSQC, HMBC, gNOE, IR and MS). Eupomatenoid-5 was the only compound active on the bacterium. The antibacterial property of P. regnellii extract provides preliminary scientific validation for the traditional medicinal use of this plant. The active compound eupomatenoid-5 should be further studied in animal models to verify in vivo efficacy and toxicity.
引用
收藏
页码:2060 / 2069
页数:10
相关论文
共 22 条
[1]   Insecticidal neolignans from Piper decurrens [J].
Chauret, DC ;
Bernard, CB ;
Arnason, JT ;
Durst, T ;
Krishnamurty, HG ;
SanchezVindas, P ;
Moreno, N ;
SanRoman, L ;
Poveda, L .
JOURNAL OF NATURAL PRODUCTS, 1996, 59 (02) :152-155
[2]  
Clinical and Laboratory Standards Institute, 2005, M27A2 CLSI
[3]  
Correa M.P., 1984, DICIONARIO PLANTAS U, P687
[4]  
Cronquist A., 1981, INTEGRATED SYSTEM CL
[5]   Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus [J].
Diep, BA ;
Gill, SR ;
Chang, RF ;
Phan, TH ;
Chen, JH ;
Davidson, MG ;
Lin, F ;
Lin, J ;
Carleton, HA ;
Mongodin, EF ;
Sensabaugh, GF ;
Perdreau-Remington, F .
LANCET, 2006, 367 (9512) :731-739
[6]   Guidelines for the control of methicillin-resistant Staphylococcus aureus [J].
Fraise, AP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (03) :287-289
[7]   Antifungal principles from Piper fulvescens [J].
Freixa, B ;
Vila, R ;
Ferro, EA ;
Adzet, T ;
Cañigueral, S .
PLANTA MEDICA, 2001, 67 (09) :873-875
[8]   Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin [J].
Hiramatsu, K ;
Aritaka, N ;
Hanaki, H ;
Kawasaki, S ;
Hosoda, Y ;
Hori, S ;
Fukuchi, Y ;
Kobayashi, I .
LANCET, 1997, 350 (9092) :1670-1673
[9]   Screening of some plants used in the Brazilian folk medicine for the treatment of infectious diseases [J].
Holetz, FB ;
Pessini, GL ;
Sanches, NR ;
Cortez, DAG ;
Nakamura, CV ;
Dias, BP .
MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2002, 97 (07) :1027-1031
[10]   Therapies and vaccines for emerging bacterial infections:: Learning from methicillin-resistant Staphylococcus aureus [J].
John, Chandy C. ;
Schreiber, John R. .
PEDIATRIC CLINICS OF NORTH AMERICA, 2006, 53 (04) :699-+